ArticleJournal of the American Geriatrics Society2022

A large pragmatic trial is the right solution for testing anti-amyloid therapies for Alzheimer's disease.

M Maria Glymour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.